TrialRheumatology international2014

Efficacy and safety of PG201 (Layla(®)) and celecoxib in the treatment of symptomatic knee osteoarthritis: a double-blinded, randomized, multi-center, active drug comparative, parallel-group, non-inferiority, phase III study.

Wan-Hee Yoo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.